Salus Discovery's goal is to lower costs and improve performance through assay simplification by leveraging micro scale phenomena. The first technology to be commercialized is Exclusion-based Sample Preparation (ESPTM). ESPTM can dramatically simplify your analyte isolation challenges while increasing assay performance.ESP works across a wide range of samples (e.g.cell lysate, blood, plants, food) and analytes (nucleic acids, proteins, cells). Current research is working on improving assays for more efficacious personalized therapies. It may provide multiple orthogonal endpoints to improve the clinicianandapos s ability to match treatment to patient.
